Mosquito-Borne Rift Valley Fever Virus Linked to Miscarriage in Humans
|
By LabMedica International staff writers Posted on 11 Oct 2016 |

Image: Proteins from Rift Valley fever virus (Photo courtesy of Medical Xpress).
Rift Valley fever virus (RVFv) has been linked to miscarriage in a cross-sectional study of pregnant Sudanese women with fever, which indicated a 7 times greater risk of miscarriage for infected women.
“In parts of Africa where there are RVF outbreaks, human miscarriages have never been linked to this particular viral infection, until now,” said co-author Magnus Evander, professor at Umeå University Faculty of Medicine (Umeå, Sweden), “With these results, we can add miscarriage to the list of known complications from RVF. This discovery is important for maternal health and for our efforts to develop preventive measures to minimize miscarriages, which are a big health problem for women in the affected areas of Africa.” The study was a collaboration between researchers at Umeå University, the Swedish Defense Research Agency (FOI), and clinicians in Sudan.
RVFv, mostly in Africa and on the Arabian Peninsula, regularly causes large outbreaks with hundreds of thousands of infected people and animals (e.g. cows, sheep, goats). RVF usually produces mild, influenza-like symptoms in humans, but in about 8% of cases, infected people develop serious symptoms, such as liver damage, serious eye infection, internal and external bleeding, meningitis, and death. In animals it often leads to death and as well as pregnancy miscarriages.
The new results are based on a study of 130 pregnant women with fever in Sudan, where outbreaks are a large and recurring health problem. Of the 130 patients, 27 had a miscarriage and 4 had premature births. The women infected with RVFv had a 7 times greater risk of miscarriage.
”Because RVF is caused by a mosquito-borne virus, there is a potential risk of global spread, which has been the case with the Zika virus. The fact that RVF could lead to miscarriage is very worrying,” said Prof. Evander.
The study was published September 27, 2016, in the journal Lancet Global Health.
Related Links:
Umeå University Faculty of Medicine
“In parts of Africa where there are RVF outbreaks, human miscarriages have never been linked to this particular viral infection, until now,” said co-author Magnus Evander, professor at Umeå University Faculty of Medicine (Umeå, Sweden), “With these results, we can add miscarriage to the list of known complications from RVF. This discovery is important for maternal health and for our efforts to develop preventive measures to minimize miscarriages, which are a big health problem for women in the affected areas of Africa.” The study was a collaboration between researchers at Umeå University, the Swedish Defense Research Agency (FOI), and clinicians in Sudan.
RVFv, mostly in Africa and on the Arabian Peninsula, regularly causes large outbreaks with hundreds of thousands of infected people and animals (e.g. cows, sheep, goats). RVF usually produces mild, influenza-like symptoms in humans, but in about 8% of cases, infected people develop serious symptoms, such as liver damage, serious eye infection, internal and external bleeding, meningitis, and death. In animals it often leads to death and as well as pregnancy miscarriages.
The new results are based on a study of 130 pregnant women with fever in Sudan, where outbreaks are a large and recurring health problem. Of the 130 patients, 27 had a miscarriage and 4 had premature births. The women infected with RVFv had a 7 times greater risk of miscarriage.
”Because RVF is caused by a mosquito-borne virus, there is a potential risk of global spread, which has been the case with the Zika virus. The fact that RVF could lead to miscarriage is very worrying,” said Prof. Evander.
The study was published September 27, 2016, in the journal Lancet Global Health.
Related Links:
Umeå University Faculty of Medicine
Latest Microbiology News
- WHO Endorses Rapid Point-of-Care Testing to Improve TB Detection
- Breath Analysis Approach Offers Rapid Detection of Bacterial Infection
- Study Highlights Accuracy Gaps in Consumer Gut Microbiome Kits
- WHO Recommends Near POC Tests, Tongue Swabs and Sputum Pooling for TB Diagnosis
- New Imaging Approach Could Help Predict Dangerous Gut Infection
- Rapid Sequencing Could Transform Tuberculosis Care
- Blood-Based Viral Signature Identified in Crohn’s Disease
- Hidden Gut Viruses Linked to Colorectal Cancer Risk
- Three-Test Panel Launched for Detection of Liver Fluke Infections
- Rapid Test Promises Faster Answers for Drug-Resistant Infections
- CRISPR-Based Technology Neutralizes Antibiotic-Resistant Bacteria
- Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
- AI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
- New Test Measures How Effectively Antibiotics Kill Bacteria
- New Antimicrobial Stewardship Standards for TB Care to Optimize Diagnostics
- New UTI Diagnosis Method Delivers Antibiotic Resistance Results 24 Hours Earlier
Channels
Clinical Chemistry
view channel
New CLIA Status Brings Mass Spectrometry Steroid Testing to Routine Labs
Steroid hormone measurement is a core application of clinical mass spectrometry, which is widely regarded as a diagnostic gold standard. Access to these high-specificity methods has often been constrained... Read more
Study Shows Dual Biomarkers Improve Accuracy of Alzheimer’s Detection
Alzheimer’s disease develops slowly, and biological changes can appear in blood many years before symptoms. While plasma assays for phosphorylated tau offer earlier detection, discerning whether these... Read moreMolecular Diagnostics
view channel
First IVDR‑Certified IGH Clonality Assay Supports Diagnosis of B-Cell Malignancies
Accurate identification of clonal immunoglobulin heavy chain (IGH) gene rearrangements is central to evaluating suspected B-cell lymphoproliferative disorders, where a single B-cell clone yields a defining... Read more
Plasma ctDNA Testing Predicts Breast Cancer Recurrence After Neoadjuvant Therapy
Accurate identification of breast cancer patients at risk of relapse after pre-surgery treatment is central to guiding adjuvant decisions, particularly in aggressive disease. Circulating fragments of tumor... Read moreHematology
view channel
Rapid Cartridge-Based Test Aims to Expand Access to Hemoglobin Disorder Diagnosis
Sickle cell disease and beta thalassemia are hemoglobin disorders that often require referral to specialized laboratories for definitive diagnosis, delaying results for patients and clinicians.... Read more
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read moreImmunology
view channel
FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas
Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Study Identifies Inflammatory Pathway Driving Immunotherapy Resistance in Bladder Cancer
Bladder cancer remains a prevalent malignancy with variable responses to immune checkpoint inhibitors. Clinicians often observe elevated C-reactive protein and interleukin-6 in affected patients, yet the... Read morePathology
view channel
Biopsy-Based Gene Test Predicts Recurrence Risk in Lung Adenocarcinoma
Lung cancer is the leading cause of cancer death, killing more people in the United States than breast, prostate, and colon cancers combined. In lung adenocarcinoma (LUAD), tumors that invade nearby blood... Read more
AI-Powered Tool to Transform Dermatopathology Workflow
Skin cancer accounts for the largest number of cancer diagnoses in the United States, placing sustained pressure on pathology services. Diagnostic interpretation can be variable for challenging melanocytic... Read moreTechnology
view channel
Rapid Biosensor Detects Drug Sensitivity in Breast Tumors
Chemotherapy selection for breast cancer is challenged by heterogeneous tumor responses. Conventional chemosensitivity assays can be slow, require large sample volumes, and struggle with complex biological... Read more
Online Tool Supports Family Screening for Inherited Cancer Risk
Genetic test results in oncology often have implications for relatives who may share inherited cancer risk. Many health systems lack structured processes to help patients alert family members, limiting... Read moreIndustry
view channel
Integrated DNA Technologies Expands into Clinical Diagnostics
Integrated DNA Technologies (IDT; Coralville, Iowa, USA) has announced the launch of Archer FUSIONPlex-HT Dx and VARIANTPlex-HT Dx. This launch marks the company’s first in vitro diagnostic (IVD) offerings... Read more








